Potassium Iodide

American Thyroid Association urges the White House to distribute potassium iodide (KI)
(March 30, 2011) (PDF File, 197 KB)

Radiation Risks to Health: A Joint Statement from the American Association of Clinical Endocrinologists, the American Thyroid Association, The Endocrine Society and the Society of Nuclear Medicine (March 18, 2011)

American Thyroid Association (ATA) requests that White House include potassium iodide (KI) protection against radiation as critical component of antiterrorism plans and response to a nuclear accident (January 25, 2007)

Potassium Iodide Pills Not Ready Despite 03′ Deadline (October 11, 2005)

ATA Comments on the National Academy of Sciences’ Report on Potassium Iodide Distribution in Event of Nuclear Accident (August 9, 2005)

Pediatric Potassium Iodide (KI) Solution Approved by the FDA (February 1, 2004)

Thyroid Experts Cite HHS Report as Misleading in Nuclear Disaster Preparedness ( December 21, 2004)

HHS KI Guidance Response Letter (December 15, 2004)

NAS Study Panel recommendations on KI

National Academy of Sciences Committee to assess the distribution of potassium iodide issue (June 2, 2003) (PDF File 70 KB)

International Experts Recommend Distributing Potassium Iodide (March 1, 2003) (PDF File, 210 KB)

American Thyroid Association endorses potassium iodide for radiation emergencies ( July 24, 2002)

Questions and answers about potassium iodide (KI)

Editorial: “Say yes to potassium iodide,” by Peter G. Crane, reprinted from the Seattle Post-Intelligencer

Web links for important documents about potassium iodide

Web links for state information about potassium iodide